The Validity of the Evaluation of Renal Artery Duplex in Critically Ill Acute Kidney Injury Patients
1 other identifier
observational
100
1 country
1
Brief Summary
This study aims to assess the clinical relevance of renal artery duplex ultrasound in critically ill patients with acute kidney injury (AKI) in terms of the renal resistive index (RRI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 10, 2025
CompletedFirst Posted
Study publicly available on registry
July 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJuly 18, 2025
July 1, 2025
2 years
July 10, 2025
July 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Renal resistivity index (RRI)
The renal resistivity index (RRI) will be assessed in patients with acute kidney injury (AKI) who require intensive care unit (ICU) admission within 24 hours.
1 week post-procedure
Study Arms (1)
Study group
Patients diagnosed with acute kidney injury (AKI).
Interventions
Renal artery duplex will be performed to all patients in terms of renal resistivity index (RRI).
Eligibility Criteria
One hundred patients admitted to the intensive care unit (ICU), all the studied populations will be diagnosed to have AKI, with no past medical history of chronic renal disease.
You may qualify if:
- Patients age \>18 years.
- Both sexes.
- Patients within 24 hours after intensive care unit (ICU) admission.
You may not qualify if:
- Patients presented with poor abdominal echogenicity.
- Chronic kidney disease, especially with estimated creatinine clearance less than 30 ml/min/1.73m.
- Patients with dialysis dependency.
- Patients with renal transplantation.
- Patients with known renal artery stenosis.
- If there is a pregnancy.
- Patients with any congenital kidney diseases as mono-kidney, anatomic kidney abnormalities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, 11591, Egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of Anesthesiology, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Study Record Dates
First Submitted
July 10, 2025
First Posted
July 18, 2025
Study Start
May 1, 2024
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
July 18, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- After the end of study for one year.
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.